Aumed, a.s., Komořanská 326/63, 143 14 Praha - Modřany, Česká republika

+420 603 587 701 English

WE DEVELOP NEW IMMUNOBIOLOGICAL PRODUCTS AND INNOVATIVE MEDICINES

ABOUT COMPANY

AUMED a.s. was established in 2007 and is now mainly engaged in research and development.. Its original focus has gradually begun to focus on the healthcare and pharmaceutical industries, where research and development activities are absolutely necessary due to new market requirements. Under the company AUMED, a.s. also include the subsidiaries AUMED Immunology a.s. and Aumed Pharma a.s.

AUMED A.S. HAS PARTICIPATED IN THE FIGHT AGAINST THE PANDEMIC OF COVID-19

In cooperation with Protean s.r.o. and Institute of Molecular and Translational Medicine, AUMED a.s. launched a modern diagnostics of SARS-CoV-2 virus under the name AUMED test RT-LAMP Assay SARS-CoV-2. AUMED, a.s. also launched a new self-sampling PCR GARGLING KIT, the principle of which is based on gargling of the oral cavity and pharynx.

NEWS

AUMED, a.s. received support for the development of a vaccine against Staphylococcus aureus

18. 12. 2023

AUMED received support for the project “Development of a new vaccine against Staphylococcus aureus”, registration number CZ.01.01.01/01/22_002/0000585. Staphylococcus aureus causes...

AUMED, a.s. received support for the development of a product for the supportive treatment of the skin in the case of atopic eczema

18. 12. 2023

AUMED received support for the project “Development of a preparation based on a cleansing spray intended for the supportive treatment...

Research projects of Aumed, a.s. are financed by the European Structural Funds and with financial support from the state budget through the Ministry of Industry and Trade. A complete list of all ongoing and completed projects with this support can be found here.

European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness


Tel.: +420 603 587 701
Komořanská 326/63, 143 14 Praha - Modřany, Česká republika
(c) 2017, Aumed a.s